Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1 Cre/+ ;Rosa26‐eYFP mice-Reference-Cited by-同舟云学术

Enzymatically stable analogue of the gut‐derived peptide xenin on beta‐cell transdifferentiation in high fat fed and insulin‐deficient Ins1 Cre/+ ;Rosa26‐eYFP mice

Published:2020-08-18 Issue:3 Volume:37 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Tanday Neil¹,Moffett R. Charlotte¹,Gault Victor A.¹,Flatt Peter R.¹,Irwin Nigel¹^ORCID

Affiliation:

1. SAAD Centre for Pharmacy and Diabetes Ulster University Coleraine Northern Ireland UK

Funder

Invest Northern Ireland

European Foundation for the Study of Diabetes

Diabetes UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3384

Reference61 articles.

1. Identification of xenin, a xenopsin‐related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion;Feurle GE;J Biol Chem,1992

2. Evaluation of the degradation and metabolic effects of the gut peptide xenin on insulin secretion, glycaemic control and satiety

3. Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism

4. Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25

5. Characterisation of the biological activity of xenin-25 degradation fragment peptides

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?;Diabetes, Obesity and Metabolism;2023-10-16

2. Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage;Peptides;2022-06

3. Classical and non-classical islet peptides in the control of β-cell function;Peptides;2022-04

4. Dual-agonist incretin peptides from fish with potential for obesity-related Type 2 diabetes therapy – A review;Peptides;2022-01

5. Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells;PLOS ONE;2021-12-20